arrow
T

Tiziana Mongini

University of Turin
H指数:50
被引数:6,910

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genetic susceptibility to thrombotic microangiopathy in a 10-month-old patient with SMA type 1: a caveat for gene therapy eligibility

脊髓性肌萎缩症1型10个月大患者对血栓性微血管病遗传易感性的警示:基因治疗适用性的注意点

2026-08-010
PRE
Assessment of IBM-FRS total score and specific functional domains in a large cohort of inclusion body myositis patients

评估IBM-FRS总分及特定功能领域在一大样本包涵体肌炎患者中的表现

2025-11-190
PRE
Landscape Analysis of COL6A1, COL6A2, and COL6A3 Pathogenic Variants in a Large Italian Cohort Presenting with Collagen VI-Related Myopathies: A Nationwide Report

COL6A1、COL6A2和COL6A3致病性变异在呈现VI型胶原蛋白相关肌病的大型意大利队列中的景观分析:一项全国性报告

2025-10-080
OAAI
Upper limb progression in Duchenne muscular dystrophy: Insights from a 36-month longitudinal study using the PUL 20

杜氏肌营养不良症上肢进展:基于36个月纵向研究使用PUL 20的见解

2025-09-180
OA
The Role of Whole-Exome Sequencing and Methylation Analysis in Untangling Complex Facioscapulo-Humeral Muscular Dystrophy Cases

全外显子组测序和甲基化分析在解开复杂面肩肱型肌营养不良病例中的作用

2025-08-110
PRE
Nucleolar FRG2 lncRNAs inhibit rRNA transcription and cytoplasmic translation, linking FSHD to dysregulation of muscle-specific protein synthesis

核仁FRG2 lncRNAs抑制rRNA转录和细胞质翻译,将FSHD与肌肉特异性蛋白质合成的失调联系起来

2025-07-221
OA
Analysis of the Italian cohort of late-onset Pompe disease (LOPD) patients after 10 and 15 years of therapy with alglucosidase alfa

意大利晚发型庞贝病(LOPD)患者接受阿糖苷酶α治疗10年和15年后的队列分析

2025-07-110
PRE
Patients on treatment with risdiplam in Italy: challenges in the interpretation of the real-world data

意大利接受risdiplam治疗的患者的真实世界数据解读挑战

2025-03-281
PRE
Prevalence of Duchenne muscular dystrophy in Italy: a nationwide survey

意大利杜氏肌营养不良症的患病率: 一项全国性调查

2024-12-160
PRE
Natural history of Becker muscular dystrophy: DMD gene mutations predict clinical severity

贝克肌营养不良的自然史:DMD基因突变预测临床严重程度

BRAIN
IF11.7
2024-11-050
PRE
Integrating D4Z4 methylation analysis into clinical practice: improvement of FSHD molecular diagnosis through distinct thresholds for 4qA/4qA and 4qA/4qB patients

将D4Z4甲基化分析整合到临床实践中: 通过4qA/4qA和4qA/4qB患者的不同阈值改善FSHD分子诊断

2024-10-221
OAAI
Clinical, Histopathologic, and Genetic Features of Patients With Myofibrillary and Distal Myopathies Experience From the Italian Network
2024-08-271
PRE
Digenic inheritance involving a muscle-specific protein kinase and the giant titin protein causes a skeletal muscle myopathy
2024-03-017
OAAI
Clinical Phenotype of Pediatric and Adult Patients With Spinal Muscular Atrophy With Four SMN2 Copies: Are They Really All Stable?

具有四个SMN2拷贝的儿童和成人脊髓性肌萎缩症患者的临床表型: 它们真的都稳定吗?

2023-09-2212
OAAI
Digital health and Clinical Patient Management System (CPMS) platform utility for data sharing of neuromuscular patients: the Italian EURO-NMD experience
2023-07-213
OAAI
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability?

动态和非动态Duchenne肌营养不良症患者PUL 2.0域的纵向分析: 它们与功能能力的关系如何变化?

2023-04-123
OAAI
Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies An Italian Nationwide Survey

意大利全国性调查显示,在疾病缓解疗法时代,脊髓性肌萎缩症的患病率

2023-03-1414
OAAI
Telemedicine in Neuromuscular Diseases During Covid-19 Pandemic: ERN-NMD European Survey
2023-03-073
OA
Adults with spinal muscular atrophy: a large-scale natural history study shows gender effect on disease

成人脊髓性肌萎缩症: 一项大规模自然史研究显示性别对疾病的影响

2022-10-1113
PRE
Expanding the clinical-pathological and genetic spectrum of RYR1-related congenital myopathies with cores and minicores: an Italian population study

扩大具有核心和微型核心的RYR1-related先天性肌病的临床病理和遗传谱: 一项意大利人口研究

2022-04-1510
OAAI